SEARCH

SEARCH BY CITATION

References

  • Balis, F.M., Lester, C.M., Chrousos, G.P., Heideman, R.L. & Poplack, D.G. (1987) Differences in cerebro-spinal-fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukaemia. Journal of Clinical Oncology, 5, 202207.
  • Burnett, A.K. & Eden, O.B. (1997) The treatment of acute leukaemia. Lancet, 349, 270275.
  • Butta, Z.A. (2000) Why has so little changed in maternal and child health in South Asia? British Medical Journal, 321, 809812.
  • Chessells, J.M., Bailey, C.C. & Richards, S.M. (1995) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of the UK Medical Research Council trial UKALL X. Lancet, 345, 143148.
  • Chessells, J.M., Swansbury, G.J., Reeves, B., Bailey, C.C. & Richards, S.M. (1997) Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. British Journal of Haematology, 99, 93100.
  • Costello, A. & Zumla, A. (2000) Moving to research partnership in developing countries. British Medical Journal, 321, 827829.
  • Coustan-Smith, E., Behm, F.G. & Sanchez, J. (1998) Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet, 351, 550554.
  • Van Dongen, J.J., Seriu, T., Panzer-Grumayer, E.R., Biondi, A., Pongers-Willemse, M.J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W.A., Gadner, H., Van Wering, E.R., Ludwig, W.-D., Basso, G., De Bruijn, M.A., Cazzaniga, G., Hettinger, K., Van Der Does-van den Berg, A., Hop, W.C., Riehm, H. & Bartram, C.R. (1998) Prognostic value of minimal residual disease in acutelymphoblastic leukaemia in childhood. Lancet, 352, 17311738.
  • Eden, O.B. (1999) Acute lymphoblastic leukaemia: Whom and when should we transplant? Pediatrics Transplantation, 3, 108115.
  • Eden, O.B., Harrison, G., Richards, S., Lilleyman, J.S., Bailey, C.C., Chessells, J.M., Hann, I.M., Hill, F.G.H. & Gibson, B.E.S. on behalf of the Medical Research Council Childhood Leukaemia Working Party (2000) Long term follow up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980–97. Leukemia, 14, 23072320.
  • Feig, S.A., Harris, R.E. & Sather, H.N. (1997) Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukaemia. A study of the Children's Cancer Study Group (CCG 1884). Medical Pediatric Oncology, 29, 534540.
  • Glazer, E.R., Perkins, C.I., Young, J.L., Schlag, R.D., Campleman, S.L. & Wright, W.E. (1999) Cancer among Hispanic children in California, 1988–94: Comparison with non-Hispanic children. Cancer, 86, 10701079.
  • Godlee, F., Horton, R. & Smith, R. (2000) Global information flow – publishers should provide information free to resource poor countries. British Medical Journal, 321, 776777.
  • Greaves, M.F. (1988) Speculations on the cause of childhood acute lymphoblastic leukaemia. Leukemia, 2, 424429.
  • Gustafsson, G., Kreuger, A., Clausen, N., Garwicz, S., Kristinsson, J. & Lie, S.O. (1998) Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high risk patients. Acta Paediatrica, 87, 11511161.
  • Hann, I.M., Richards, S.M., Eden, O.B. & Hill, F.G.H. on behalf of the Medical Research Council Childhood Leukaemia Working Party (1998) Analysis of the immunophenotype of children treated on the Medical Research Council UK Acute lymphoblastic leukaemia trial XI (MRC UKALL XI). Leukemia, 12, 12491255.
  • Hann, I.M., Vora, A.J., Richards, S.M., Hill, F.G.H., Gibson, B.E.S., Lilleyman, J., Kinsey, S., Mitchell, C. & Eden, O.B. on behalf of theUK Medical Research Council's Working Party on childhoodleukaemia (2000) Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL 97 randomised trials. Leukemia, 14, 356363.
  • Hann, I.M., Vora, A.J., Harrison, G., Harrison, C., Eden, O.B., Hill, F., Gibson, B. & Richards, S. (2001) Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia – results from MRC UKALL XI. British Journal of Haematology, 113, 103114.
  • Hargrave, D.R., Hann, I.M., Richards, S.M., Hill, F.G., Lilleyman, J.S., Kinsey, S., Bailey, C.C., Chessells, J.M., Mitchell, C. & Eden, O.B. (2001) Progressive reduction in treatment related deaths in MRC childhood lymphoblastic leukaemia trials from 1980 to 1997. British Journal of Haematology, 112, 293299.
  • Harris, E. & Tanner, M. (2000) Health technology transfer. British Medical Journal, 321, 817820.
  • Kinlen, L.J. (1995) Epidemiological evidence for an infective basis in childhood leukaemia. British Journal of Cancer, 71, 15.
  • Lee, K. & Mills, A. (2000) Strengthening governance for global health research. British Medical Journal, 321, 775776.
  • Lorenzana, R., Coustan-Smith, E., Antillon, F., Ribeiro, R.C. & Campana, D. (2000) Simple methods for the rapid exchange of flow cytometry data between remote centers. Leukemia, 14, 336346.
  • Masera, G., Baez, F., Biondi, A., Cavilli, F., Conter, V., Flores, A., Fontana, G., Fossati Bellani, F., Lanfranco, P., Malta, A., Mendez, G., Ocampo, E., Pacheco, C., Riva, L., Sala, A., Silva, F., Sessa, C. & Tognoni, G. (1998) North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet, 352, 19231926.
  • Nachman, J.B., Sather, H.N., Sensel, M.G., Trigg, M.E., Cherlow, J.M., Lukens, J.N., Wolff, L., Uckun, F.M. & Gaynon, P.S. (1998) Augmented post-induction therapy for children with highrisk acute lymphoblastic leukaemia and a slow response to initial therapy. New England Journal of Medicine, 338, 16631671.
  • Parkin, D.M., Kramárová, E., Draper, G.J., Masuyer, E., Michaelis, J., Neglia, J., Qureshi, S. & Stiller, C.A. (1998) International Incidence of Childhood Cancer, Volume II. IARC Scientific Publications No 144.
  • Pui, C.-H. & Evans, W.E. (1998) Acute lymphoblastic leukaemia. New England Journal of Medicine, 339, 605615.
  • Ribeiro, R.C. & Bonilla, M. (2000) A leukaemia treatment programme in El Salvador. Lancet Perspectives, 356, 57.
  • Riehm, H., Gadner, H., Henze, G., Kornhuber, B., Langermann, H.J., Müller-Weinrich, S. & Schellong, G. (1998) Acute lymphoblastic leukaemia. Treatment results in 3 BFM studies (1970–81). In: Leukaemia Research: Advances in Cell Biology and Treatment (ed. by S.B.Murphy & J.R. Gilbert), pp. 251263. Elsevier Biomedical, New York.
  • Rubnitz, J.E., Downing, J.R. & Pui, C.-H. (1997) Tel gene rearrangements in acute lymphoblastic leukaemia: a new genetic marker with prognostic significance. Journal of Clinical Oncology, 15, 11501157.
  • Schrappe, M., Reiter, A. & Riehm, H. (1996) Cytoreduction and prognosis in childhood acute lymphoblastic leukaemia. Journal of Clinical Oncology, 14, 24032406.
  • Schrappe, M., Camitta, B. & Pui, C.-H. On Behalf Of Eden, T., Gaynon, P., Gustafsson, G., Janka-Schaub, G.E., Kamps, W., Masera, G., Sallan, S., Tsuchida, M. & Vilmer, E. (2000a) Spotlight on long term results of pediatric ALL clinical trials from 12 study Groups worldwide (with a note from the editor N. Muller-Berat). Leukemia, 14, 21932195.
  • Schrappe, M., Reiter, A., Zimmerman, M., Harbott, J., Ludwig, W.-D., Henze, G., Gadner, H., Odenwald, E. & Riehm, H. (2000b) Long term results of four consecutive trials in childhood ALL performed by the ALL – BFM Study Group from 1981 to 1995. Leukemia,14, 22052222.
  • Sitthi-amorn, C. & Somrongthong, R. (2000) Strengthening health research capacity in developing countries: a critical element for achieving health equity. British Medical Journal, 321, 813815.
  • Smith, M.A., Simon, R., Strickler, H.D., McQuillan, G., Ries, L.A.G. & Linet, M.S. (1998) Evidence that childhood acute lymphoblastic leukaemia is associated with an infectious agent linked to hygiene conditions. Cancer Causes and Control, 9, 285298.
  • Steinherz, P.G., Gaynon, P.S., Breneman, J.C., Cherlow, J.M., Grossman, N.J., Kersey, J.H., Johnstone, H.S., Sather, H.N., Trigg, M.E., Chappell, R., Hammond, D. & Bleyer, W.A. (1996) Cytoreduction and prognosis in acute lymphoblastic leukaemia – the importance of early marrow response, report from the Children's Cancer Group. Journal of Clinical Oncology, 14, 389398.
  • Taylor, G.M., Dearden, S., Payne, N., Ayres, M., Gokhale, D., Birch, J., Blair, V., Stevens, R.F., Will, A.M. & Eden, O.B. (1998) Evidence that an HLA-DQA1 – DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection related aetiology. British Journal of Cancer, 78, 561565.
  • Veerman, A.J.P., Hählen, K., Kamps, W.A., Van Leeuwen, E.F., De Vaan, G.A.M. & Slob, U. (1996) High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukaemia: results of protocol ALL VI from the Dutch Childhood Leukaemia Study Group. Journal of Clinical Oncology, 14, 911918.
  • Wilimas, J.A. & Ribeiro, R.C. (2001) Pediatric haematology-oncology outreach for developing countries: in Pediatric Oncology in the 21st century (Part 1) (ed. by M.J.Coppes, D.G.Tubergen & R.Arceci). Hematology/Oncology Clinics of North America, 15, 775787.